[Prevention of thromboembolic complications in cancer patients].
D000925:Anticoagulants; D001777:Blood Coagulation / Q000187:drug effects; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000097:blood*; D009525:Niacin / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D009525:Niacin; D006493:Heparin
Profilaktika tromboembolicheskikh oslozhneniĭ u onkologicheskikh bol'nykh.